MediciNova, Inc.
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inf…
Biotechnology
US, La Jolla [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
MediciNova, Inc. has no acquisition track records yet.
M&A Deals · History
MediciNova, Inc. has no acquisition track records yet.